论文部分内容阅读
前三精制药董事长、哈药股份董事刘占滨在被调查期间跳楼身亡,让事态持续发酵。刘被调查的原因尚未公布,有人猜测是内部举报所致,也有传言说他树敌太多。刘占滨生前在哈药集团工作了27年,200g年接手三精制药后迅速让陷入困境的三精制药业绩再创新高,但从2013年开始,三精制药盈利能力大幅下滑,然而营销费用却连年居高不下。广告营销环节最易滋生腐败,刘落马很可能与此有关。受此影响,
Former Sanjing Pharmaceutical chairman, director of Harbin Pharmaceutical shares Liu Zhanbin jumped to his death during the investigation, so that the situation continues to ferment. Liu was investigated the reasons have not been announced, it was speculated to be caused by internal reports, there are rumors that he too many enemies. Liu Zhanbin worked for Harbin Pharmaceutical Group for 27 years before his death. After taking 200ml of Sanjing Pharmaceutical Co., Ltd., Sanjing Pharmaceutical made another record high in performance in 200g. However, since 2013, the profitability of Sanjing Pharmaceutical has dropped sharply. However, High. Advertising marketing most prone to corruption, Liu Lok Ma is likely to be related. influenced by,